Forecast & Rating4 analysts currently cover Atara Biotherap, of which 3 give a positive rating. The average price target is $13.67, about 71.3% upside from the current price of $7.98. Coverage is limited, so the data is for reference only. Data as of Jun 18, 2026; this does not constitute investment advice.
Jun 18, 2026
Price forecast
$13.6771.26%
Forecast & RatingBuy
4analysts
Strong buy75.00%
Buy0.00%
Hold25.00%
Sell0.00%
Strong sell0.00%
Strong buy
3
Buy
0
Hold
1
Sell
0
Strong sell
0
Target price forecast
Forecast baselineJul 26, 2026
Forecast met21.6%
Stock price$7.98
Average forecast price$19.0
Highest forecast price$25
Lowest forecast price$16
Average forecast price
$19.0
Highest forecast price
$25
Lowest forecast price
$16
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.